![What you need to know before you go to Sea Air Space 2025 [VIDEO]](https://breakingdefense.com/wp-content/uploads/sites/3/2024/05/Screen-Shot-2024-05-14-at-12.19.19-PM.png?#)
.jpg)
GSK pens $2.5B pact for ABL Bio's tech to help antibodies bypass blood-brain barrier
GSK has continued to flesh out its neuroscience strategy with a 2 billion pound ($2.5 billion) deal to use a South Korean company’s tech to bypass the blood-brain barrier.
GSK has continued to flesh out its neuroscience strategy with a 2 billion pound ($2.5 billion) deal to use a South Korean company’s tech to bypass the blood-brain barrier.
